Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cloretazine enters phase II AML/MDS trial

March 31, 2004

Orathecin NDA accepted for filing

March 31, 2004

AR6BD-25, a novel monoclonal antibody with anticancer activity

March 30, 2004

Insight into the mechanism of action behind antitumor activity of auraptene

March 30, 2004

Use of CXCR5 receptor as target for diagnosis and treatment of cancer, cardiovascular diseases, etc.

March 30, 2004

GlaxoSmithKline patent describes thiophene compounds as polo-like kinase 1 inhibitors

March 30, 2004

Clinical experience with Tumor Necrosis Therapy shared

March 30, 2004

Anastrozole improves the outcome of breast cancer surgery

March 30, 2004

Benefits reported for exemestane as first-line treatment for advanced breast cancer

March 30, 2004

Antitumor activity of JNJ-7706621, an orally available CDK inhibitor, demonstrated in vivo

March 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026